1. Home
  2. Labeler Index
  3. Fresenius Kabi Usa, Llc
  4. 63323-269
  5. NDC Package Code: 63323-269-94 Diprivan

NDC Package 63323-269-94 Diprivan

Propofol Injection, Emulsion Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
63323-269-94
Package Description:
10 VIAL in 1 BOX / 20 mL in 1 VIAL (63323-269-43)
Product Code:
63323-269
Proprietary Name:
Diprivan
Non-Proprietary Name:
Propofol
Substance Name:
Propofol
Usage Information:
DIPRIVAN is an IV general anesthetic and sedation drug that can be used as described in the table below.  Table 3.  Indications for DIPRIVAN IndicationApproved Patient PopulationInitiation and maintenance of Monitored Anesthesia Care (MAC) sedationAdults onlyCombined sedation and regional anesthesiaAdults only (see PRECAUTIONS)Induction of General AnesthesiaPatients greater than or equal to 3 years of ageMaintenance of General AnesthesiaPatients greater than or equal to 2 months of ageIntensive Care Unit (ICU) sedation of intubated, mechanically ventilated patientsAdults onlySafety, effectiveness and dosing guidelines for DIPRIVAN have not been established for MAC Sedation in the pediatric population; therefore, it is not recommended for this use (see PRECAUTIONS, Pediatric Use).DIPRIVAN is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations.In the Intensive Care Unit (ICU), DIPRIVAN can be administered to intubated, mechanically ventilated adult patients to provide continuous sedation and control of stress responses only by persons skilled in the medical management of critically ill patients and trained in cardiovascular resuscitation and airway management.DIPRIVAN is not indicated for use in Pediatric ICU sedation since the safety of this regimen has not been established (see PRECAUTIONS, Pediatric Use).DIPRIVAN is not recommended for obstetrics, including Cesarean section deliveries. DIPRIVAN crosses the placenta, and as with other general anesthetic agents, the administration of  DIPRIVAN may be associated with neonatal depression (see PRECAUTIONS).DIPRIVAN is not recommended for use in nursing mothers because propofol has been reported to be excreted in human milk, and the effects of oral absorption of small amounts of propofol are not known (see PRECAUTIONS).
11-Digit NDC Billing Format:
63323026994
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1808217 - propofol 1000 MG in 100 ML Injection
  • RxCUI: 1808217 - 100 ML propofol 10 MG/ML Injection
  • RxCUI: 1808217 - propofol 1000 MG per 100 ML Injection
  • RxCUI: 1808219 - DIPRIVAN 1000 MG in 100 ML Injection
  • RxCUI: 1808219 - 100 ML propofol 10 MG/ML Injection [Diprivan]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Fresenius Kabi Usa, Llc
    Dosage Form:
    Injection, Emulsion - An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Intravenous - Administration within or into a vein or veins.
  • Intravenous - Administration within or into a vein or veins.
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • PROPOFOL 10 mg/mL
  • PROPOFOL 10 mg/mL
  • PROPOFOL 10 mg/mL
  • PROPOFOL 10 mg/mL
    • Pharmacologic Class(es):
  • General Anesthesia - [PE] (Physiologic Effect)
  • General Anesthetic - [EPC] (Established Pharmacologic Class)
  • General Anesthesia - [PE] (Physiologic Effect)
  • General Anesthetic - [EPC] (Established Pharmacologic Class)
  • General Anesthesia - [PE] (Physiologic Effect)
  • General Anesthetic - [EPC] (Established Pharmacologic Class)
  • General Anesthesia - [PE] (Physiologic Effect)
  • General Anesthetic - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    NDA019627
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    11-13-2009
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 63323-269-94 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    63323026994J2704Inj, propofol, 10 mg10 MG201020200

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    63323-269-1010 VIAL in 1 BOX / 10 mL in 1 VIAL
    63323-269-1610 VIAL in 1 BOX / 10 mL in 1 VIAL (63323-269-06)
    63323-269-2910 VIAL in 1 BOX / 20 mL in 1 VIAL (63323-269-22)
    63323-269-3710 VIAL in 1 BOX / 20 mL in 1 VIAL (63323-269-25)
    63323-269-5020 VIAL in 1 BOX / 50 mL in 1 VIAL (63323-269-30)
    63323-269-5720 VIAL in 1 BOX / 50 mL in 1 VIAL (63323-269-23)
    63323-269-5920 VIAL in 1 BOX / 50 mL in 1 VIAL (63323-269-45)
    63323-269-6510 VIAL in 1 BOX / 100 mL in 1 VIAL (63323-269-35)
    63323-269-6710 VIAL in 1 BOX / 100 mL in 1 VIAL (63323-269-21)
    63323-269-6910 VIAL in 1 BOX / 100 mL in 1 VIAL (63323-269-41)
    63323-269-7010 VIAL in 1 BOX / 20 mL in 1 VIAL (63323-269-33)
    63323-269-7720 VIAL in 1 BOX / 50 mL in 1 VIAL (63323-269-75)
    63323-269-7810 VIAL in 1 BOX / 100 mL in 1 VIAL (63323-269-31)

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 63323-269-94?

    The NDC Packaged Code 63323-269-94 is assigned to a package of 10 vial in 1 box / 20 ml in 1 vial (63323-269-43) of Diprivan, a human prescription drug labeled by Fresenius Kabi Usa, Llc. The product's dosage form is injection, emulsion and is administered via intravenous form.

    Is NDC 63323-269 included in the NDC Directory?

    Yes, Diprivan with product code 63323-269 is active and included in the NDC Directory. The product was first marketed by Fresenius Kabi Usa, Llc on November 13, 2009 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 63323-269-94?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 63323-269-94?

    The 11-digit format is 63323026994. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-263323-269-945-4-263323-0269-94